Survival Differences Among Uterine Papillary Serous, Clear Cell and Grade 3 Endometrioid Adenocarcinoma Endometrial Cancers
Authors:
- Jerry LiuJLJerry Liu
- Tamara KalirTKTamara Kalir
- Manjeet ChadhaMCManjeet Chadha
- Vishal GuptaVGVishal Gupta
- 1 January 2017
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 27 (1) , 85-92
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Molecular Profile of Grade 3 Endometrioid Endometrial CarcinomaAmerican Journal of Surgical Pathology, 2012
- Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluationGynecologic Oncology, 2012
- High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and OutcomesInternational Journal of Gynecological Pathology, 2010
- Controversies in the Management of Endometrial CarcinomaObstetrics and Gynecology International, 2010
- Clinicopathologic Analysis of 187 High-grade Endometrial Carcinomas of Different Histologic Subtypes: Similar Outcomes Belie Distinctive Biologic DifferencesAmerican Journal of Surgical Pathology, 2007
- Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometriumGynecologic Oncology, 2004
- Uterine serous and grade 3 endometrioid carcinomasCancer, 2004
- The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid CarcinomaGynecologic Oncology, 2000
- Early Pathologic Stage Clear Cell Carcinoma and Uterine Papillary Serous Carcinoma of the EndometriumInternational Journal of Gynecological Pathology, 1995
- Clear cell carcinoma of the endometrium: A histopathological and clinical study of 97 casesGynecologic Oncology, 1990